AI Biology Startup Boltz Raises $110M Series A Led by Bessemer
AI biology startup Boltz announced a $110M Series A led by Bessemer, working with 6 of the world's top 20 pharma companies. Benchling and numerous industry figures publicly congratulated the team, citing strong demand.
2026-11-18 ~ 2026-11-18 · 2 related posts
- Industry figures congratulate Boltz on its $110M Series A — GabriCorso · 2026-11-18
- AI biology startup Boltz raises $110M Series A, backed by Benchling's enthusiasm — GabriCorso · 2026-11-18